» Articles » PMID: 29182350

Using the 4 Pillars to Increase Vaccination Among High-risk Adults: Who Benefits?

Overview
Journal Am J Manag Care
Specialty Health Services
Date 2017 Nov 29
PMID 29182350
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To compare changes in vaccination rates (pneumococcal polysaccharide vaccine [PPSV]; tetanus, diphtheria, and pertussis [Tdap] vaccine; and influenza vaccine) among high-risk adults following an intervention (June 1, 2013, to January 31, 2015) that used the 4 Pillars Practice Transformation Program (4 Pillars Program).

Study Design: Post hoc analysis of data from a randomized controlled cluster trial.

Methods: Eighteen primary care practices received staff education, guidance for using the 4 Pillars Program, and support for a practice immunization champion. Paired t tests were used to compare vaccination rates separately for those with diabetes, chronic lung or chronic heart disease, or other high-risk conditions. Student's t tests were used to compare vaccination rates across high-risk conditions. Generalized estimating equation modeling was used to determine the likelihood of vaccination.

Results: Based on International Classification of Diseases, Ninth Revision, Clinical Modification codes, 4737 patients aged 18 to 64 years were identified as having diabetes (n = 1999), chronic heart disease (n = 658), chronic lung disease (n = 1682), or another high-risk condition (n = 764). PPSV uptake increased by 12.2 percentage points (PP), Tdap vaccination increased by 11.4 PP, and influenza vaccination increased by 4.8 PP. In regression analyses, patients with diabetes (odds ratio [OR], 2.2; 95% CI, 1.80-2.73), chronic lung disease (OR, 1.50; 95% CI, 1.21-1.87), or chronic heart disease (OR, 1.32; 95% CI, 1.02-1.71) were more likely to receive PPSV than those without the respective high-risk condition. Those with diabetes (OR, 1.14; 95% CI, 1.01-1.28) or chronic lung disease (OR, 1.14; 95% CI, 1.01-1.30) were more likely to receive an influenza vaccine than those without the respective condition. The likelihood of Tdap vaccination was not significantly associated with any of the chronic conditions tested.

Conclusions: An intervention including the 4 Pillars Program was associated with significant increases in vaccination of high-risk adults. However, the overall uptake of recommended vaccines for those with high-risk conditions remained below national goals.

Citing Articles

Digital Gamification Tool (Let's Control Flu) to Increase Vaccination Coverage Rates: Proposal for Algorithm Development.

Lopes H, Baptista-Leite R, Hermenegildo C, Atun R JMIR Res Protoc. 2024; 13:e55613.

PMID: 39255031 PMC: 11422745. DOI: 10.2196/55613.


Burden of Vaccine-Preventable Diseases in People Living with HIV.

Samaha H, Yigitkanli A, Naji A, Kazzi B, Tanios R, Dib S Vaccines (Basel). 2024; 12(7).

PMID: 39066418 PMC: 11281599. DOI: 10.3390/vaccines12070780.


Behavioral interventions for vaccination uptake: A systematic review and meta-analysis.

Malik A, Ahmed N, Shafiq M, Elharake J, James E, Nyhan K Health Policy. 2023; 137:104894.

PMID: 37714082 PMC: 10885629. DOI: 10.1016/j.healthpol.2023.104894.


A review of factors influencing vaccination policies and programs for older adults globally.

Eiden A, Barratt J, Nyaku M Hum Vaccin Immunother. 2023; 19(1):2157164.

PMID: 36656057 PMC: 9980618. DOI: 10.1080/21645515.2022.2157164.


Cost-effectiveness of revised US pneumococcal vaccination recommendations in underserved minority adults < 65-years-old.

Wateska A, Nowalk M, Lin C, Harrison L, Schaffner W, Zimmerman R Vaccine. 2022; 40(50):7312-7320.

PMID: 36336526 PMC: 9999373. DOI: 10.1016/j.vaccine.2022.10.066.


References
1.
Grohskopf L, Sokolow L, Olsen S, Bresee J, Broder K, Karron R . Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season. MMWR Morb Mortal Wkly Rep. 2015; 64(30):818-25. PMC: 5779578. DOI: 10.15585/mmwr.mm6430a3. View

2.
Shea K, Edelsberg J, Weycker D, Farkouh R, Strutton D, Pelton S . Rates of pneumococcal disease in adults with chronic medical conditions. Open Forum Infect Dis. 2015; 1(1):ofu024. PMC: 4324183. DOI: 10.1093/ofid/ofu024. View

3.
Lau D, Hu J, Majumdar S, Storie D, Rees S, Johnson J . Interventions to improve influenza and pneumococcal vaccination rates among community-dwelling adults: a systematic review and meta-analysis. Ann Fam Med. 2012; 10(6):538-46. PMC: 3495928. DOI: 10.1370/afm.1405. View

4.
Duval L, George C, Hedrick N, Woodruff S, Kleinpeter M . Network 13 partnership to improve the influenza, pneumococcal pneumonia, and hepatitis B vaccination rates among dialysis patients. Adv Perit Dial. 2011; 27:106-11. View

5.
Williams W, Lu P, OHalloran A, Bridges C, Kim D, Pilishvili T . Vaccination coverage among adults, excluding influenza vaccination - United States, 2013. MMWR Morb Mortal Wkly Rep. 2015; 64(4):95-102. PMC: 4584858. View